Cite

HARVARD Citation

    Daskalakis, K. et al. (2019). Anti-tumour activity of everolimus and sunitinib in neuroendocrine neoplasms. Endocrine connections. 8 (6), pp. 641-653. [Online]. 
  
Back to record